Literature DB >> 32393490

Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus.

Razieh Kebriaei1, Katherine Lev1, Taylor Morrisette1, Kyle C Stamper1, Jacinda C Abdul-Mutakabbir1, Susan M Lehman2, Sandra Morales3, Michael J Rybak4,5.   

Abstract

Comparative time-kill experiments with Staphylococcus aureus bacteriophage (phage) Sb-1 alone and phage-antibiotic combinations (PACs) against two methicillin-resistant S. aureus (MRSA) strains have shown synergy with both daptomycin-phage and vancomycin-phage combinations. PACs prevented development of phage resistance and demonstrated bactericidal activity for all triple combinations. In addition, the extracellular membrane vesicle (MV) formation and the potential impact of phage on MV suppression were examined. Our results demonstrate the potential of PAC for combating MRSA infections.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Staphylococcus aureus; bacteriophage therapy; combination therapy

Mesh：

Substances：

Year:  2020        PMID： 32393490      PMCID： PMC7318012          DOI： 10.1128/AAC.00461-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  49 in total

Review 1.  Revenge of the phages: defeating bacterial defences.

Authors:  Julie E Samson; Alfonso H Magadán; Mourad Sabri; Sylvain Moineau
Journal:  Nat Rev Microbiol       Date:  2013-08-27       Impact factor: 60.633

Review 2.  Phage Therapy in the Postantibiotic Era.

Authors:  Fernando L Gordillo Altamirano; Jeremy J Barr
Journal:  Clin Microbiol Rev       Date:  2019-01-16       Impact factor: 26.132

3.  Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin.

Authors:  Marzia Rahman; Shukho Kim; Sung Min Kim; Sung Yong Seol; Jungmin Kim
Journal:  Biofouling       Date:  2011-11       Impact factor: 3.209

4.  Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.

Authors:  Francisco M Marty; Wendy W Yeh; Christine B Wennersten; Lata Venkataraman; Esperanza Albano; Edwin P Alyea; Howard S Gold; Lindsey R Baden; Satish K Pillai
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

Review 5.  Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi.

Authors:  Lisa Brown; Julie M Wolf; Rafael Prados-Rosales; Arturo Casadevall
Journal:  Nat Rev Microbiol       Date:  2015-09-01       Impact factor: 60.633

6.  Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.

Authors:  George Sakoulas; Jack Brown; Kenneth C Lamp; Lawrence V Friedrich; Kimberly C Lindfield
Journal:  Clin Ther       Date:  2009-09       Impact factor: 3.393

7.  Bacteriophage-resistant mutants in Yersinia pestis: identification of phage receptors and attenuation for mice.

Authors:  Andrey A Filippov; Kirill V Sergueev; Yunxiu He; Xiao-Zhe Huang; Bryan T Gnade; Allen J Mueller; Carmen M Fernandez-Prada; Mikeljon P Nikolich
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

8.  Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms.

Authors:  Waqas Nasir Chaudhry; Jeniffer Concepción-Acevedo; Taehyun Park; Saadia Andleeb; James J Bull; Bruce R Levin
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

Review 9.  Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.

Authors:  Eun Ju Choo; Henry F Chambers
Journal:  Infect Chemother       Date:  2016-12

10.  Staphylococcus aureus Membrane-Derived Vesicles Promote Bacterial Virulence and Confer Protective Immunity in Murine Infection Models.

Authors:  Fatemeh Askarian; John D Lapek; Mitesh Dongre; Chih-Ming Tsai; Monika Kumaraswamy; Armin Kousha; J Andrés Valderrama; Judith A Ludviksen; Jorunn P Cavanagh; Satoshi Uchiyama; Tom E Mollnes; David J Gonzalez; Sun N Wai; Victor Nizet; Mona Johannessen
Journal:  Front Microbiol       Date:  2018-02-20       Impact factor: 6.064
View more
  10 in total

1.  Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an In Vitro Pharmacokinetic/Pharmacodynamic Model.

Authors:  Razieh Kebriaei; Katherine L Lev; Kyle C Stamper; Susan M Lehman; Sandra Morales; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

2.  Evaluation of Bacteriophage Cocktails Alone and in Combination with Daptomycin against Daptomycin-Nonsusceptible Enterococcus faecium.

Authors:  Taylor Morrisette; Katherine L Lev; Gregory S Canfield; Breck A Duerkop; Razieh Kebriaei; Kyle C Stamper; Dana Holger; Susan M Lehman; Smaranda Willcox; Cesar A Arias; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2021-11-01       Impact factor: 5.938

3.  Characterization of a Novel Bacteriophage Henu2 and Evaluation of the Synergistic Antibacterial Activity of Phage-Antibiotics.

Authors:  Xianghui Li; Tongxin Hu; Jiacun Wei; Yuhua He; Abualgasim Elgaili Abdalla; Guoying Wang; Yanzhang Li; Tieshan Teng
Journal:  Antibiotics (Basel)       Date:  2021-02-09

Review 4.  Deploying Viruses against Phytobacteria: Potential Use of Phage Cocktails as a Multifaceted Approach to Combat Resistant Bacterial Plant Pathogens.

Authors:  Tahir Farooq; Muhammad Dilshad Hussain; Muhammad Taimoor Shakeel; Muhammad Tariqjaveed; Muhammad Naveed Aslam; Syed Atif Hasan Naqvi; Rizwa Amjad; Yafei Tang; Xiaoman She; Zifu He
Journal:  Viruses       Date:  2022-01-18       Impact factor: 5.048

Review 5.  Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.

Authors:  Marzanna Łusiak-Szelachowska; Ryszard Międzybrodzki; Zuzanna Drulis-Kawa; Kathryn Cater; Petar Knežević; Cyprian Winogradow; Karolina Amaro; Ewa Jończyk-Matysiak; Beata Weber-Dąbrowska; Justyna Rękas; Andrzej Górski
Journal:  J Biomed Sci       Date:  2022-03-30       Impact factor: 8.410

6.  Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro: Bacteriophage-Antibiotic Combination.

Authors:  Razieh Kebriaei; Katherine L Lev; Rahi M Shah; Kyle C Stamper; Dana J Holger; Taylor Morrisette; Ashlan J Kunz Coyne; Susan M Lehman; Michael J Rybak
Journal:  Microbiol Spectr       Date:  2022-03-29

7.  Bactericidal Synergism between Phage YC#06 and Antibiotics: a Combination Strategy to Target Multidrug-Resistant Acinetobacter baumannii In Vitro and In Vivo.

Authors:  Jun Luo; Libo Xie; Min Liu; Qianyuan Li; Peng Wang; Chunhua Luo
Journal:  Microbiol Spectr       Date:  2022-06-23

Review 8.  Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections.

Authors:  Dana Holger; Razieh Kebriaei; Taylor Morrisette; Katherine Lev; Jose Alexander; Michael Rybak
Journal:  Antibiotics (Basel)       Date:  2021-05-11

9.  Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium.

Authors:  Katherine Lev; Ashlan J Kunz Coyne; Razieh Kebriaei; Taylor Morrisette; Kyle Stamper; Dana J Holger; Gregory S Canfield; Breck A Duerkop; Cesar A Arias; Michael J Rybak
Journal:  Antibiotics (Basel)       Date:  2022-03-15

Review 10.  Considerations for the Use of Phage Therapy in Clinical Practice.

Authors:  Gina A Suh; Thomas P Lodise; Pranita D Tamma; Jane M Knisely; Jose Alexander; Saima Aslam; Karen D Barton; Erica Bizzell; Katherine M C Totten; Joseph L Campbell; Benjamin K Chan; Scott A Cunningham; Katherine E Goodman; Kerryl E Greenwood-Quaintance; Anthony D Harris; Shayla Hesse; Anthony Maresso; Veronique Nussenblatt; David Pride; Michael J Rybak; Zoe Sund; David van Duin; Daria Van Tyne; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2022-01-18       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.